- Blog
- 06.16.2022
Category: Blog
- Blog
- 06.13.2022
Enclara Trainers Gear Up for Launch of E3 Pro Hospice Medication Management App
When Enclara Pharmacia launched its E3 MobileTM application in 2017, most hospice nurses were used to calling in patient prescriptions. The new application allowed nurses...
- Blog
- 04.29.2022
Evaluating Five of the Most Common Complementary Therapies in Hospice Care
Therapeutic alternatives to conventional Western medicine have long been a staple of many hospice programs due to their shared focus on comfort and quality of...
- Blog
- 04.01.2022
Drug Shortages Continue to Impact Hospice Providers in 2022
Over the last two years, Americans have become increasingly familiar with the concept of supply chains and just how fragile they can be. Of course,...
- Blog
- 03.30.2022
Enclara in the News: Ealia Washington, PharmD, CGP, BCACP Sits Down With Hospice News
In this Voices interview, our Senior Director of IPU Operations, Ealia Washington, PharmD, CGP, BCACP, sits down with Hospice News to learn the ins and...
- Blog
- 03.25.2022
Women’s History Month: Recognizing Four Founders of Hospice Care
March is Women’s History Month and here at Enclara we are reflecting on the prominent role women have played in the hospice community from its...
- Blog
- 02.28.2022
1-2-3 Ways to Connect With Enclara at NHPCO LAC 2022
For the first time in three years, hospice professionals will gather in-person for NHPCO’s Leadership and Advocacy Conference (LAC) March 7-9 at the Gaylord National...
- Blog
- 02.16.2022
Enclara in the News: Karen Bergenholtz, RN, MSN, CRNP Sits Down With Hospice News
In this Voices interview, our Senior Director of Implementation & Education, Karen Bergenholtz, RN, MSN, CRNP, sits down with Hospice News to learn about the top...
- Blog
- 01.22.2022
Enclara in the News: Natasha M.S. Jackson, PharmD Sits Down With Hospice News
In this Voices interview, our Director of Training and Education, Natasha M.S. Jackson, PharmD, sits down with Hospice News to learn about the disparities and...